Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-03T19:47:54.893Z Has data issue: false hasContentIssue false

A conceptual framework for the developmental origins of health and disease

Published online by Cambridge University Press:  09 December 2009

P. D. Gluckman*
Affiliation:
Liggins Institute and the National Research Centre for Growth and Development, The University of Auckland, Auckland, New Zealand Singapore Institute for Clinical Sciences, A*STAR (Agency for Science, Technology and Research), Singapore
M. A. Hanson
Affiliation:
Developmental Origins of Health and Disease Division, Institute of Developmental Sciences, University of Southampton, Southampton, UK
T. Buklijas
Affiliation:
Liggins Institute and the National Research Centre for Growth and Development, The University of Auckland, Auckland, New Zealand
*
Address for correspondence: P. D. Gluckman, Liggins Institute, The University of Auckland, Private Bag 92019, Auckland 1023, New Zealand. (Email pd.gluckman@auckland.ac.nz)
Rights & Permissions [Opens in a new window]

Abstract

In the last decades, the developmental origins of health and disease (DOHaD) have emerged as a vigorous field combining experimental, clinical, epidemiological and public health research. Its goal is to understand how events in early life shape later morbidity risk, especially of non-communicable chronic diseases. As these diseases become the major cause of morbidity and mortality worldwide, research arising from DOHaD is likely to gain significance to public health and economic development. But action may be hindered by the lack of a firm mechanistic explanation and of a conceptual basis, especially regarding the evolutionary significance of the DOHaD phenomenon. In this article, we provide a succinct historical review of the research into the relationship between development and later disease, consider the evolutionary and developmental significance and discuss the underlying mechanisms of the DOHaD phenomenon. DOHaD should be viewed as a part of a broader biological mechanism of plasticity by which organisms, in response to cues such as nutrition or hormones, adapt their phenotype to environment. These responses may be divided into those for immediate benefit and those aimed at prediction of a future environment: disease occurs in the mismatch between predicted and realized future. The likely mechanisms that enable plasticity involve epigenetic processes, affecting the expression of genes associated with regulatory pathways. There is now evidence that epigenetic marks may be inherited and so contribute to non-genomic heritable disease risk. We end by discussing the global significance of the DOHaD phenomenon and its potential applications for public health purposes.

Type
Review
Copyright
Copyright © Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2009

Introduction

The idea that disease risk can be passed across generations is not new. Much effort has been devoted to understanding the mechanisms underlying such heritability, yet it success has been limited as the extent of heritability for many complex traits is not clearly known and may have been exaggerated in traditional family based studies (twin and adoption). Genome-wide association studies (GWAS), after several years of intense research, have produced strong associations with certain diseases but nonetheless account for only a small fraction of their occurrence.Reference Goldstein1Reference Chi3 Although polymorphisms associated with particular disease traits or risk factors such as obesity have been discovered, the attributable risk in the general population on a purely fixed genetic basis for such common conditions is very small.4 To solve the problem of ‘missing heritability’ several other avenues have been proposed.Reference Maher5 The first concerns the finding of rare genetic variants with strong effects, not identified in GWAS. This approach is now increasingly possible thanks to the sharp decrease in sequencing cost.Reference Hayden Check6 The second avenue relates to the effects resulting from copy-number variations (CNVs), which are often not identified in GWAS. Gene-gene interactions (epistasis) offer a further opportunity. Finally, interactions between genes and environment provide a large and promising source of heritability. Within this field, epigenetics, in its narrow sense a study of molecular mechanisms that establish and maintain mitotically stable patterns of gene expression yet do not alter DNA sequence, is a burgeoning field.Reference Allis, Jenuwein and Reinberg7 As we shall show later, it holds a strong promise for elucidating the emergent body of knowledge now known as the developmental origins of health and disease (DOHaD).

The understanding of DOHaD is further enriched by setting it in a broader, biological and evolutionary context. In the second half of the twentieth century, a new set of intellectual and empirical approaches, often abbreviated to evo-devoReference Amundsen8 and eco-devo,Reference Gilbert9 appeared, exploring how development and environment interact with evolved mechanisms to drive phenotypic development and evolution. Developmental systems theory was an influential example of the reaction of evolutionary theorists and philosophers to the prevalent genetic determinism with its manifest flaws.Reference Oyama10 It is in this historical context and within this conceptual framework, drawing on fields from epigenetics to evolutionary biology, that we need to understand the phenomenon of DOHaD.

The need for such an understanding is evident at several levels. Firstly, the DOHaD field has been repeatedly charged with being merely a collection of phenomenological associations.Reference Kramer and Joseph11, Reference Huxley, Neil and Collins12 A theoretical and mechanistic explanation of how and why early life events can affect disease vulnerability in later life is, thus, critical. Furthermore, a framework is necessary not only to encompass the proximate causes of the relationships between early life events and later life pathophysiology but also for the ultimate mechanisms, that is their evolutionary significance.

Without such understanding, the overall relevance of the observed phenomena cannot be understood and the question of whether several distinct processes have been lumped into one, under the general term DOHaD, cannot be answered. Such conceptual and mechanistic considerations are essential if the DOHaD field is to receive greater consideration in designing public health preventative approaches. This review, therefore, opens with a brief historical overview, then focuses on conceptual and mechanistic basis of the DOHaD phenomenon and briefly comments on the public health implications.

Development, evolution and biological thought

Development has had a chequered history in medical and biological thought. In the 1800s, embryology was a key biological discipline that, together with comparative anatomy, promised to elucidate both ontogeny as well as phylogeny at a single stroke.Reference Hopwood13 Following Jean-Baptiste Lamarck, who argued that organic evolution proceeded by somatic modifications which resulted from the development of particular habits, Etienne Geoffroy St-Hilaire founded the field of teratology which aimed to elucidate evolutionary mechanisms. He saw artificially produced embryonic malformations, ‘monsters’, as the result of the arrest of development that could provide insight into evolutionary pathways.Reference Richards14, Reference Oppenheimer15 But by the 1880s the increasing lack of consensus among scientists regarding the relative weight of embryological v. comparative evidence in understanding the animal form engendered a disciplinary crisis. Embryologists shifted their attention from evolutionary to narrower developmental questions they hoped to address with mechanistic experiments, while the emerging field of genetics replaced embryology as the core of evolutionary studies, and indeed of biology more widely. Genes became seen as the only source of heritable variation and other approaches were increasingly deemed controversial or even unscientific. For instance, using the model of midwife toads, which in normal conditions mate on land, the Viennese biologist Paul Kammerer tested the proposal that acquired characteristics may be inherited by changing environmental conditions.Reference Gliboff16 He artificially exposed the toads to dry, heated environment in F0 generation and showed that the resulting change in reproductive behaviour – mating in water – persisted down to F6, even when environmental conditions reverted to the original ones. Yet he was accused of fraud and his subsequent suicide in 1926 was understood as an admission of guilt. Only recently his work has been seriously re-examined and the possibility of an epigenetic explanation reconsidered.Reference Vargas17

The idea that the heritable basis may be changed by the environment acting either directly or indirectly, termed as ‘soft inheritance’ by Ernst Mayr and associated with Lamarck and Geoffroy St-Hilaire, was further marred by its association with the ideologically charged and scientifically flawed version of Neo-Lamarckism pioneered by Trofim Lysenko and adopted by the Soviet establishment.Reference Roll-Hansen18 However teratology gained new importance from the 1930s onwards with investigations into how nutritional factors, X-rays, viruses and then pharmaceutical agents might disrupt development. Yet this discipline has, however, remained focused almost exclusively on disrupted development that is clearly outside the normal range.

Only late in the twentieth century, development began to make a comeback to the forefront of life sciences. At first its return reflected the dominance of genetics, as the emergent discipline of (molecular) developmental biology approached development as a set programme of precisely timed gene expression. The supremacy of genetics was furthermore evident in an increasingly wide search for the genetic basis for disorders presumed to have a heritable basis.

The emergence of the DOHaD concept

Some of the first suggestions, based on epidemiological, clinical and experimental observations, that early life events might have long-term effects on the risks of disease came from European and American researchers working in a novel environment of technological innovation and rapid social change. In the 1930s it was suggested that childhood conditions influenced later mortality.Reference Kermack, McKendrick and McKinlay19 But it was only in the early 1970s that a series of papers by the East German endocrinologist Günter Dörner and his group proposed that the conditions before and soon after birth were related to later risks of arteriosclerosis and obesity, and that gestational diabetes presented a risk for subsequent diabetes mellitus.Reference Dörner20Reference Dörner and Mohnike23 Dörner’s work was used in East German public health measures to support longer maternity leave and breastfeeding;Reference Dörner, Rodekamp and Plagemann24 indeed discussion on the long-term benefits of breast v. bottle feeding, later given great impetus by LucasReference Lucas25, has remained an important part of DOHaD research. Conceptually, Dörner also contributed by introducing the term ‘programming’ (die Programmierung) in the sense that it is now, rightly or wrongly, used and he argued for the notion of ‘functional teratogenesis’ to describe the observed phenomena.Reference Dörner, Rodekamp and Plagemann24, Reference Dörner26 Along the same lines and at the same time, the diabetologist Norbert Freinkel developed the hypothesis of ‘fuel-mediated teratogenesis’ to explain how the metabolic state of the mother could influence her offspring as well as intergenerational transmission of risk of diabetes. In his 1980 Banting lecture, he stated that ‘developing fetal structures may be exquisitely attuned to fine alterations in maternal fuel economy… It is suggested that concepts of teratogenesis should be expanded to include alterations occurring subsequent to organogenesis during the differentiation and proliferation of fetal cells. Such changes could cause long-range effects upon behavioral, anthropometric and metabolic functions.’Reference Freinkel27 In a series of important studies (e.g. De Prins and Van AsscheReference De Prins and Van Assche28), Frans Van Assche and his group showed that offspring of rats experimentally growth-restricted by uteroplacental arterial ligation had both insulin resistance and abnormalities of the pancreatic islets. They also showed that experimentally induced diabetes mellitus in the dam could pass risk of metabolic dysfunction to her offspring.Reference Aerts and Van Assche29

Independently, scientists working with epidemiological and historical demographical data came to similar general conclusions. In 1977, Anders Forsdahl pointed out that there were relationships between the conditions at the beginning of life and the risks of cardiovascular disease in later life.Reference Forsdahl30 In 1985, Michael Wadsworth reported in a study of the 36-year-old members of the UK national birth cohort that birth weight was related to blood pressure, but did not comment on its significance.Reference Wadsworth, Cripps, Midwinter and Colley31 In the same year a Finnish study linked poverty in childhood with increased risk of ischemic heart disease, myocardial infarction and coronary death.Reference Notkola, Punsar, Karvonen and Haapakoski32 In 1986, David Barker reported a correlation between the geographical distribution of infant mortality and of later cardiovascular disease in the UK.Reference Barker and Osmond33 In 1988, a Swedish group reported that low birth weight was a significant factor in the later risk of hypertension.Reference Gennser, Rymark and Isberg34 A contemporary study of Arizona Pima Indians showed that intrauterine environment was an important determinant of the development of diabetes.Reference Pettitt, Aleck, Baird, Carraher, Bennett and Knowler35 These observations were soon followed by the much more extensive and multiple studies of Barker’s group, which continue to this day, and then by many others.Reference Godfrey36 While cardiovascular and metabolic diseases have remained the dominant focus of DOHaD, epidemiological and clinical studies have reported relationships between birth weight and a range of other conditions, such as osteoporosis, mental health disorders including depression and schizophrenia, risks of certain cancers, obstructive lung disease and asthma, as well as cognitive ability.Reference Cooper, Walker-Bone, Arden and Dennison37Reference Jefferis, Power and Hertzman42

Animal studies have been an important part of DOHaD research from its early days, supporting epidemiological observations and testing hypotheses that for obvious ethical reasons could not be examined in humans; many are reviewed in this article. Caution has to be applied in extrapolating from animal experiments to observations in humans: while the key principles of fetal nutrition and its supply line are closely related in all mammalian species, there are important differences in maternal metabolism, placental structure, relative composition of fetal diets, growth rate, body composition of the offspring, as well as other aspects. The sensitivity and response to nutritional interventions may thus differ.Reference Harding43 While researchers are aware of the limitations of each animal model,Reference McMullen and Mostyn44 they nevertheless indicate helpful avenues for research.

The theoretical basis of DOHaD

From the earliest days of the field, researchers have suggested theoretical models that explained the DOHaD phenomenon. The accumulation of clinical and experimental data raised new questions, in the first place: ‘Why does early life experience become manifest in the modern world as an increased risk of metabolic and other disease?’, and then later: ‘Why have such prenatal processes been selected during evolution and why do they result in disease in adults?’ Most current DOHaD research focuses on what evolutionary biology generally terms as ‘proximate’ causes, that is physiological mechanisms involved in an observed effect.Reference Mayr45 While such research is essential, a conceptual framework must also encompass ‘ultimate’ causes, which describe the phenomenon in terms of its evolutionary origin and in particular the fitness benefit which allowed the DOHaD phenomenon to be selected and then to be maintained within a lineage and the processes by which it develops. This section is devoted to the discussion of the latter.

Evolutionary processes revolve around selection for maintaining the reproductive fitness, not the health or lifespan. The human life span is now much longer than 26 years, the estimated mean life expectancy at birth in the Palaeolithic when Homo sapiens evolved,Reference Cohen and Armelagos46 although there has always been a significant proportion of the population who lived substantially longer.

In the early 1960s James Neel first suggested that the major changes in lifestyle – including diet, nutrition and exercise expenditure – of the modern world contributed to disease risk because humans exceeded a genetically limited capacity to adapt.Reference Neel47 He argued that some populations had been selected for ‘thrifty genes’ to survive periods of famine; such populations were now at risk in a world of abundant nutrition. While the ‘thrifty genotype’ concept has major limitations and has thus been much criticized,Reference Kuzawa, Gluckman, Hanson, Fantuzzi and Mazzone48 the search for thrifty genes remains a dominant part of the gene-dominated research into the determinants of heart disease and diabetes.

In 1992, David Barker and Nicholas Hales offered a developmental alternative to the thrifty genotype hypothesis, which built on the evolutionary concept of trade-offs.Reference Hales and Barker49 According to their original model, the fetus in difficult circumstances trades-off growth to survive in utero but might then suffer later adverse consequences. Developmental trade-offs are common in many species: for example, the spadefoot toad will trade-off growth during development by undergoing early metamorphosis in drought conditions, increasing the chance of reproductive success at the expense of greater risk of predation associated with smaller size.Reference Denver, Mirhadi and Phillips50 The ‘thrifty phenotype’ hypothesis of Barker and Hales proposed that the nutritionally deprived fetus limited its growth by developing insulin resistance in order to survive to birth. Whilst this may have conveyed a fitness advantage in a postnatally nutritionally poor environment, it resulted in an increased later disease risk if the nutritional environment became enriched. This model provided an insightful initial non-genetic explanation of the DOHaD concept. Yet the proximate explanation inherent in this model may be inadequate, as subsequent data have suggested that growth-restricted infants do not develop insulin resistance until later after birth and in some animal models of DOHaD insulin resistance is preceded by a period of greater insulin sensitivity.Reference Reusens and Remacle51 Furthermore, like many initial conceptual approaches in other domains, the Barker-Hales model had limitations: it placed fetal growth on the causal pathway; it assumed that the change in development was always induced by signals of deprivation; and it assumed a need for a severe insult or stress to the fetus. All of these assumptions have now been shown to be invalid. In particular the focus on low birth weight has been the subject of much criticism and caused much confusion. This has probably slowed research progress, with some researchers arguing that confounding variables had not been adequately taken into account.Reference Huxley, Neil and Collins12, Reference Dawes, Borruto and Zacutti52 The emphasis on low birth weight has led to a bias towards teratogenic classes of model and experiment. This in turn led sceptics to assume that DOHaD processes contributed little to the risk of developing common non-communicable diseases (NCDs), as the proportion of low birth weight in most populations is relatively small. That the effects occur across the entire normal range of birth size, and are not a function of low birth weight per se, was commonly ignored. Finally, the model artificially separated fetal and postnatal cues, and neglected the importance of peri- and even preconceptional periods, now thought to be critical.

A new evolutionary model that took into account these limitations became necessary. Bateson and ourselves addressed the question of ultimate cause by suggesting, independentlyReference Bateson53, Reference Gluckman and Hanson54 and then collectively,Reference Bateson, Barker and Clutton-Brock55 that the embryo, fetus or infant draws information from its environment and adjusts its developmental trajectory accordingly but that, in doing so, it could suffer from longer term consequences. In other words, DOHaD was a manifestation of the normal processes of developmental plasticity. Plasticity provides a developing organism with the capacity to respond to environmental change, which may occur in a regular or an irregular way and on a time scale that may be from one to several generations. This is a time scale that is thus intermediate between selection processes and homeostasis. The evolutionary advantage is obvious: if the environment is unstable, plasticity makes survival more likely by better matching the organism to its environment. We suggested that severe insults which disrupted the developmental programme and caused gross abnormalities should be treated separately from lesser ones, and that the term ‘teratogenesis’ should be restricted to the former, in contrast to Dörner’s and Freinkel’s earlier proposals.Reference Gluckman, Hanson, Spencer and Bateson56

We saw heuristic value in identifying two classes of potentially adaptive responses: those where the fetus had to make phenotypic responses for immediate benefit and those where the fetus altered its phenotypic development for potential later fitness advantage. We termed the latter ‘predictive adaptive responses’. It is important to note that these definitions reflect ends of a continuum: indeed, it would be expected that immediate responses might also be accompanied by predictive responses although the reverse need not be the case. The latter scenario might, however, reflect the sensitivity with which the phenotype can be characterised. Both classes of responses to cues within the normal range of fetal exposures are part of the processes of developmental plasticity.

Predictive or anticipatory adaptive responses can be made to nutritional or hormonal signals from the mother (in utero or during lactation), and they allow the fetus or neonate to anticipate its future and adjusts its trajectory of phenotypic development accordingly.Reference Gluckman, Hanson and Spencer57 Predictive adaptive responses may occur together or in isolation from immediately adaptive responses depending on the situation, nature and magnitude of the cue. It is important to point out that these are integrated responses affecting multiple components of the phenotype: endocrine and reproductive function, development of adipocytes and myocytes, central nervous system function, endothelial function and intermediary metabolism.Reference Gluckman, Hanson and Beedle58 These are analogous to polyphenisms in other species (see below) where developmental cues can induce quite distinct phenotypes which affect multiple systems. The only difference is that, whereas polyphenisms refer to apparently very distinct phenotypes, in the phenomena we are considering the phenotypic variation appears to be continuous. But, in fact, in many cases of insect polyphenisms intermediate forms are observed. As we will discuss later, there may be effects in mammals that might be considered polyphenic.

Potentially anticipatory responses are common in many taxa. For example, in polyphenic species, such as the African locust or the plant-hopper, the phenotype induction by early life environmental signals occurs at a time when there can be no immediate advantage.Reference Applebaum and Heifetz59 The ‘decision’ by the locust larva to develop the migratory phenotype, characterized by an omnivorous diet, fat-based metabolism and large wings, is made at a time when it cannot fly and is induced by chemical signals from its parent(s) about population density. As developmental constraints generally limit plasticity in most organs to early life, the fetus, embryo, neonate or larva must take what cues it can and make the best developmental ‘choices’. In this way, developmental plasticity fills the gap between evolutionary selection, which operates on a time base of many generations, and homeostasis, which operates on a time base of minutes to days. Indeed, a better description of predictive responses might be to posit that the trajectory of development is altered by the developmental cue with potentially adaptive consequences to the phenotype at different stages in the life course: infant obesity may represent, for example, a predicted need for adipose reserves to buffer the brain against nutritional insults at or after weaning as suggested by Kuzawa,Reference Kuzawa, Gluckman, Hanson, Fantuzzi and Mazzone48 accelerated puberty is an appropriate fitness response to high extrinsic mortality (see below) and reduced muscle, mass and insulin resistance developing in adulthood is indeed an appropriate thrifty response as posited by Barker and Hales.Reference Hales and Barker49

Plasticity has a high energetic cost and hence in general is limited to an early phase of development because re-engineering the body after the phenotype has been fully developed is costly. Experimental and clinical evidence suggests that the plastic phase in humans extends from conception through the weaning period, which in pre-modern times extended at least for the first 2–3 postnatal years. Because the windows of plasticity are not the same for different effector components, the timing of experimental insults can be expected to produce differing outcomes. For example, prolonging prenatal undernutrition into the infant period in the rat may modify some aspects of the resulting metabolic phenotypeReference Desai, Gayle, Babu and Ross60 but not obviate the change in tempo of puberty, whereas a different timing of the nutritional challenge affects both.Reference Sloboda, Howie and Vickers61

While many physicians find the concepts of anticipation in developmental biology difficult to grasp, much of biological development is anticipatory (see below). Even bacteria have been reported to show adaptive prediction.Reference Mitchell, Romano and Groisman62 A simple human example is the thickened heel pads on the feet of infants at birth – in this case the prediction is reliable and has been assimilated into genomic determinants – there is no evolutionary explanation for these which does not involve an anticipatory component. While this is an example of a developmental process, which is fixed in the genome, it is still a predictive response.

For predictions to be accurate, the environment should remain the same from conception to the adulthood. But environments can change within a life course. However, Jablonka et al. have pointed out that the fidelity of the prediction need not be high for it to confer a selective advantage and indeed, as pointed out above, much of the advantage may be in childhood and in the young adult period.Reference Jablonka, Oborny and Molnar63, Reference Moran64 Jablonka has shown the fitness enhancing advantage of such predictive responses when environments shift on a time-base equivalent from 0.5 to 2 generation times for the species. While these mechanisms evolved in invertebrates and persist in vertebrates, the challenge for the mammalian fetus is that its ability to read the future environment is compounded by the imperfect transduction of environmental information from its mother. The mother may consume a diet or have a workload or social situation unrepresentative of the contemporary environment in general; she may suffer from pathological conditions such as hypertension, gestational diabetes or placental insufficiency. Yet, although mammals may have lower fidelity in their predictive adaptive responses, we would argue that the process evolved and has been sustained because it nonetheless confers sufficient adaptive advantage.Reference Gluckman and Hanson65

Kuzawa has pointed out there is evolutionary value in having a degree of ‘inertia’ in the cueing of such anticipatory responses: for a fetus trying to anticipate its likely future environment, cues from the mother which represent aspects of the environment integrated over her lifetime may be a better indicator than short-term environmental signals operating only during development.Reference Kuzawa66 Thus, maternal body composition at conception appears to be an important cue to the developing embryo.Reference Bloomfield, Oliver and Hawkins67, Reference Ronnenberg, Wang and Xing68 The nature of the signalling is unclear, but likely to be reflected in the composition of tubal or uterine fluids. Some nutrient-dependent signalling has a longer time base: for example, the presence of insulin-like growth factor (IGF) binding proteins means that some components of IGF-1 and 2 mediated responses respond to slow, rather than acute, changes in maternal nutrition.Reference Boyne, Thame and Bennett69 Similarly, placental metabolism of hormones such as glucocorticoids provides a buffering mechanism against minor fluctuations in maternal plasma hormone levels.

We have here placed the emphasis on predictive adaptive responses, but there is no sharp distinction between these and the immediate responses mentioned earlier. Similar mechanisms are likely to be involved, albeit to a different degree. Indeed, one would expect that, whenever there is an immediate adaptive response, there will also be induction of responses for later potential advantage. However, in the case of less extreme cues the developmental trajectory may be altered subtly and have no obvious immediate phenotypic effects.

This general model allows for both a high and low nutrition environment as well as for other cues such as stress to affect later outcomes. It allows for effects within the unexceptional and expected range of fetal exposures and so it permits explanation of why the phenomenon has been retained through evolution.

There has been some debate whether immediate adaptive responses are made for maternal or for fetal benefit. Jonathan Wells has argued that maternal survival is the driver of this response: that is, the fetus does not make responses for its advantage but that responses are driven by the maternal needs.Reference Wells70 This might well be the case in polytocous, frequently reproducing species which manipulate reproductive performance much more than slow monotocous reproducers. But the weight of evidence in humans would suggest that these immediate adaptive responses primarily act for fetal/offspring advantage: by definition, they will thus improve maternal fitness.

There are several lines of evidence against applying Wells’ proposition in humans. The first comes from the effects of severe environmental challenges, when maternal preservation, if biologically important to our species, should be most obvious. Unlike some other species, humans do not completely cease reproduction during famine conditions or employ embryonic diapause to match the progression of pregnancy and birth to nutritional environments. Even in extreme nutritional environments fetal development is remarkably normal, as demonstrated by the relatively subtle effects on the birth weights of the offspring of Dutch Winter Famine pregnancies.Reference Smith71 Further, there are considerable data to show that the maternal condition at the beginning of pregnancy is a major determinant of pregnancy outcomes.Reference Bloomfield, Oliver and Hawkins67, Reference Painter, Roseboom and Bleker72, Reference MacLaughlin, Walker, Roberts, Kleemann and McMillen73 This accords with Kuzawa’s proposition that the fetus is able to mount an response to environmental conditions integrated over a longer time-base, in order to forecast the future environment.Reference Kuzawa66 In humans, lactation is remarkably well sustained in famine conditions too, suggesting that the available energetic supplies are invested to produce viable offspring, who will then have a chance to reproduce themselves. It seems probable that fetal growth retardation in humans generally has an adaptive value for the offspring: as shown by data in both humans and rats, those born smaller have earlier onset of puberty.Reference Sloboda, Howie and Vickers61, Reference Sloboda, Hart, Doherty, Pennell and Hickey74 This is perhaps the equivalent of the accelerated tempo of maturation seen in the spadefoot toad under adverse environmental conditions, suggesting that if the forecast includes the expectation that life may be shorter, accelerated reproductive maturation ensures a chance for gene flow to the next generation. But perhaps the most compelling argument against Wells’ concept comes from the (DOHaD) phenomenon in which long-term effects can be shown independently of any obvious fetal responses. For example, vascular structure and function in children is related to maternal diet before and during pregnancy independent of birth weight.Reference Gale, Jiang and Robinson75 There is no evidence in such effects that the fetus was compromised for maternal benefit.

There are generally limits on the environmental conditions, which the fetus can detect and thus predict, partially because there are limits on the nutrient or endocrine signals, which reach it and partially because of our evolutionary history. Species have not evolved with the ability to respond to environments that exceed the experience of their lineage – when they experience such environments, pathological outcomes are likely.Reference Gluckman and Hanson76 In humans, the phenomenon of ‘maternal constraint’ effectively overrides purely genetic influences on fetal growth. The size of the fetus is limited to match maternal size so that vaginal delivery is possible.Reference Gluckman and Hanson77 Maternal constraint is a continuous process and a manifestation of developmental plasticity. It is present in other mammals, but its role in humans allowed Homo sapiens to develop a large brain, delivery being timed to a point when head size was likely to be limiting, with rapid postnatal growth thereafter. But, in addition, it may have conferred a fitness advantage, because it would always limit development to match a poorer postnatal environment than exists, giving a fail-safe phenotype. The selective advantage of such an asymmetrical response has been modelled.Reference Sultan and Spencer78

The modern world is very different for much of the world’s population from that in which Homo spp. evolved, especially in relation to lifestyle, longevity, risk of infectious disease and nutrition.Reference Neel47, Reference Cordain, Eaton and Sebastian79 Moreover these aspects of the environment can change very rapidly. They have done so within a generation in the developed world, with major changes in the sources of food, with migration, and with socio-economic improvement in the developing world. The likelihood of a mismatch developing between the environment anticipated during development and the actual environment encountered later is thus greater. Human phenotypes are increasingly likely to be mismatched to the contemporary world.

The scope of the general model

Dörner and Freinkel initiated a concept that we now recognize as DOHaD, but a broader recognition emerged with the enormous contribution of Barker, which led to a focus on poor fetal conditions reflecting maternal undernutrition and/or stress and/or disease. While the latter area has dominated in the last two decades of research, there is now a growing interest in the effects of nutrient excess. There are data showing that fetuses exposed to higher cholesterol levels have a higher capacity to cope with a cholesterol load postnatally,Reference Norman and LeVeen80 perhaps because of predictive changes in their metabolism. Larger human fetuses are also less likely to get metabolic disease for a given body weight that those who are smaller.Reference Forsen, Eriksson and Tuomilehto81

Yet since the early work of Dörner and Freinkel, it has become clear that the dramatically increased access to food in recent decades and the linked rise in maternal obesity and diabetes can have consequences for the offspring by creating a second developmental pathway to obesity.Reference Gluckman, Hanson, Beedle and Raubenheimer82

It should be remembered that obese mothers may give birth either to smaller children, as a result of their own pathological conditions, or to children of normal to large birth size who later become obese. The latter outcome may be mediated in a manner similar to gestational diabetes,Reference Pettitt, Lawrence and Beyer83 by inducing fetal hyperinsulinemia and consequent high fat cell number, possibly by exposing the fetus to increased oxidative stress associated with high fatty acid transferReference Gluckman and Hanson77, Reference McCurdy, Bishop and Williams84 or it may involve quite distinct mechanisms. In such studies, the relative effects of pre- v. postnatal nutrition cannot easily be separated: both postnatal growth and mode of infant feeding are undoubtedly important factors.Reference Lucas25 Studies of the developmental contribution to later obesity are furthermore complicated by confounders such as parental genomic and psychosocial input. While it was shown that high maternal pre-pregnancy body mass index (BMI) increases the relative risk of offspring obesity,Reference Stettler, Tershakovec and Zemel85 a recent study, which tried to account for genomic influences by using paternal BMI and common genetic variants predisposing to type 2 diabetes mellitus via BMI, showed a relatively weak effect of maternal pregnancy BMI.Reference Lawlor, Timpson and Harbord86 This effect was thus unlikely to make a major contribution to the offspring obesity but could produce a slow and steady increase in obesity over multiple generations.

Both the ultimate and proximate mechanisms of the effects of maternal obesity are still unclear and this remains an important research question within the DOHaD field. However, recent experimental studies show high fat diets both induce not only obesity in the offspring but also accelerated puberty with sustained ovarian function.Reference Sloboda, Howie, Pleasants, Gluckman and Vickers87 We have posited that this may reflect an optimisation strategy whereby the fetus predicts a nutritionally rich environment and can increase its fitness facultatively by extending is postnatal reproduction.Reference Sloboda, Howie, Pleasants, Gluckman and Vickers87

There is no reason why these developmental considerations should be limited to embryonic and fetal life. The infant remains dependent on its mother for nutritional and other cues, and, while there are ultimately temporal limits on plasticity because of energetic costs, the infant can respond to environmental cues in ways similar to the fetus. Allowance must be made for pathway limitations, however, because as development proceeds there are increasing constraints on the degree of plasticity possible. There is an extensive literature on the long-term effects of inadequate or excessive infant nutrition, for example from certain types of formula feeding.Reference Hanson, Fall, Robinson and Baird88

The model can equally be applied to the compelling body of experimental literature relating maternal or infant stress, glucocorticoid exposure or maternal nursing behaviour to later effects on the offspring.Reference Meaney89 In each case, the adaptive advantage of an appropriate prediction is obvious, and the potential for a maladaptive response, if the later environment does not match the prediction, exists. Other experimental evidence has suggested that exposure to prenatal salt loadingReference Ross, Desai, Guerra and Wang90 or of infants to changed temperatures can induce phenotypic effects.Reference Diamond91 The predictive model can well incorporate such observations.

Interestingly, the phenotypes that emerge from models that manipulate nutrition or stress are remarkably similar.Reference Gluckman, Hanson, Cooper and Thornburg92 By and large, the prediction of a poor environment leads to obesity as well as altered insulin sensitivity, cardiovascular function, hypothalamic-pituitary-adrenal axis and mood. Over the course of evolution, predation and nutritional stress were probably closely linked, so it is possible that common signalling systems are involved. For example, maternal undernutrition reduces the placental activity of 11 beta-hydroxysteroid dehydrogenase type 2, thus exposing the fetus to higher levels of active glucocorticoids.Reference Bertram, Trowern, Copin, Jackson and Whorwood93 Most experimental studies, however, have used single exposures to high doses of synthetic glucocorticoids, which cross the placenta. There are, however, a few studies that have investigated chronic stress in the rodent and, while the data suggest phenotypically similar outcomes, the phenotypes are, not surprisingly, more subtle. The data on chronic stress in humans is much more confusing and this reflects the difficulties of extrapolation in this domain from animal models to humans, for example, because a wide range of social and cultural influences can be involved, and ‘stress’ is harder to define or measure in humans.

The proximate mechanisms

In medicine, phenomenology without consideration of underlying mechanisms is not well received. From the first epidemiological observations in the DOHaD field, the major criticism was that of biological implausibility. How could something acting at the beginning of life have effects, which were delayed until middle and old age? From a medical point of view, without knowledge of an underlying mechanism, developing a plausible way to intervene between early life and later disease risk remains elusive. However, once underlying mechanisms are understood, then biomarkers could be developed to predict risk early in life. This would permit interventions to be better targeted and it would also allow health professionals to get away from the use of proxy measures of development such as birth weight: a baby weighing 3.3 kg may have had an optimal, impaired or excessive trajectory of development. The trajectory it experienced affects how one might assess preventative or intervention strategies.

A growing amount of experimental data suggests that epigenetic processes explain a considerable amount of the DOHaD phenomenon. Work on tissue differentiation arising from the stem cell field clearly shows that epigenetic mechanisms, including DNA methylation and changes in histone structure, are central to cellular differentiation and developmental plasticity.Reference Reik94 Additionally, epigenetic processes can affect the expression of genes associated with regulatory pathways through life. The specific mechanisms by which cells and tissues sense environmental conditions, inducing epigenetic change, are as yet unknown. Research on ratsReference Lillycrop, Phillips, Jackson, Hanson and Burdge95Reference Park, Stoffers, Nicholls and Simmons97 and primatesReference Aagaard-Tillery, Grove and Bishop98 has shown epigenetic changes in genes associated with metabolism and endocrine function in response to maternal nutritional state. Not only the type but also the timing of the challenge seems to play a role too. Feeding a methyl-deficient diet around conception to mature sheep altered the methylation status of 4% of CpG islands in the offspring and resulted in a range of clinical symptoms in their adulthood: increased fatness, lower muscular mass, an altered immune response, insulin resistance and elevated blood pressure. The effect was mostly found in males.Reference Sinclair, Allegrucci and Singh99 Another study showed that late gestational and, especially, periconceptional exposure to famine in humans results in a partially sex-specific alteration of the methylation profiles of loci implicated in growth, metabolic and cardiovascular disease.Reference Tobi, Lumey and Talens100 While DNA methylation is probably the best studied epigenetic mechanism, the importance of non-coding RNAs is rapidly becoming more evident and it seems likely that they are central to developmental and epigenetic processes.Reference Amaral, Dinger, Mercer and Mattick101

In our studies in rats, we have not only shown that maternal undernutrition leads to permanent changes in expression of several genes associated with metabolic and endocrine regulation in the liver of adult offspring, but that these are underpinned by DNA methylation and histone structure changes in the promoters of these genes. In the low protein model, the phenotype and expression changes are prevented by supplementing the maternal diet with folate, which also reverses the epigenetic change.Reference Lillycrop, Phillips, Jackson, Hanson and Burdge95 When leptin is administered to the infant rat, it prevents the development of the metabolic phenotype.Reference Vickers, Gluckman and Coveny102 This treatment is associated with normalisation of both the expression and methylation changes,Reference Gluckman, Lillycrop and Vickers103 as if leptin signals to the infant offspring that they are well-nourished. Leptin in the infant rat can influence the development of the hypothalamusReference Bouret and Simerly104, Reference Delahaye, Breton and Risold105 and also has some peripheral actionsReference Morioka, Asilmaz and Hu106 although the mechanistic basis of the neonatal leptin effect remains to be fully elucidated. The recent observations that a leptin antagonist has the opposite effects suggest that this may be a physiologically important process in determining the metabolic phenotype.Reference Elinav, Niv-Spector and Price107

The leptin experiment, supported by other observations,Reference Stoffers, Desai, DeLeon and Simmons108, Reference Wyrwoll, Mark, Mori, Puddey and Waddell109 raises the possibility that epigenetic processes are responsible for the mammalian equivalent of polyphenisms observed in insects. The effects of leptin on subsequent gene expression induced by the prior maternal nutritional exposure were not just quantitatively but directionally different.Reference Gluckman, Lillycrop and Vickers103 This suggests that mammals have a range of morphs adapted to nutritional plane. Early life exposures might lead in some individuals to a phenotype better adapted to a higher plane of nutrition, while others may be adapted to a lower plane. It is important to note that such morphs must reflect integrated phenotypes. A morph anticipating a lower nutritional environment might expect a shorter life and invest less for longevity and more for early reproduction.Reference Gluckman, Hanson and Beedle58 This would explain a lower nephron and neuronal count in experimental animals subjected to antenatal steroids or maternal undernutrition. In this regard, childhood obesity in those with a poor start to life might reflect a strategy to accelerate weight gain, important for allowing a female to be energetically capable of supporting reproduction at an earlier age.

If the polyphenism concept has validity, then it might explain the varying relationships seen between body fat distribution and insulin resistance in different populations: for example, the ‘thin-fat’ Indian baby v. the Caucasian baby.Reference Whincup, Gilg and Papacosta110, Reference Yajnik, Fall and Coyaji111 A further piece of empirical evidence is provided from studies of survivors of kwashiorkor and marasmus. After rehabilitation, these have very different capacities to mobilise protein and fat.Reference Jahoor, Badaloo and Reid112 Within a population in Jamaica, children developing marasmus had lower birth weights than those suffering from kwashiorkor. The collected data are compatible with a model suggesting that marasmic children are better adapted to a lower nutrient environment than kwashiorkor children, adapted to a high nutrient environment.

Most recently, we have shown that the epigenetic profile at birth can predict phenotypic outcomes at 9 years of age and that this is independent of birth weight. Indeed we found that approximately 50% of the variance in body composition at 9 years of age could be explained by the methylation state of specific CpGs on candidate genes.Reference Godfrey, Gluckman and Lillycrop113 While it is still too early to draw definite conclusions as such associations need to be replicated, our studies suggest that a far greater proportion of individual vulnerability to disease may arise in development than has generally been considered, even by advocates of DOHaD. We have also shown that first-borns have different methylation and expression profiles than subsequent children, supporting the concept of maternal constraint discussed earlier. If these data are confirmed, epigenetic measures will provide a powerful tool for assessing the incidence of altered developmental trajectories in the population.

Finally, the question of heritability of the developmentally induced phenotype remains a pressing, if also controversial and difficult, question. How can environmental influences operating in one generation, especially during development, have biological echoes in subsequent generations? In a year that celebrates both the bicentenary of Charles Darwin’s birth, 150 years of On the origin of species and the bicentenary of Jean-Baptiste Lamarck’s Philosophie Zoologique, it is important to note that while the modern synthesis largely ignored the so-called ‘soft’ inheritance, an authoritative, recent review based on a substantial body of evidence showed that transgenerational epigenetic inheritance may be found across all taxa, and that it affects a range of traits, through several epigenetic mechanisms acting on diverse genetic loci.Reference Jablonka and Raz114 Physiologists working on mammalian, mostly rat and mouse, models have demonstrated that epigenetic marks can be inherited at least by the F2 generation.Reference Burdge, Hanson, Slater-Jeffries and Lillycrop115, Reference Gluckman, Hanson and Beedle116 In specialised models such as the Agouti mouse, where epigenetic processes are associated with retrotransposon silencing and the offspring develop obesity and other characteristics, the amplification of effect over several generations is prevented by dietary methyl donor supplementation.Reference Waterland, Travisano, Tahiliani, Rached and Mirza117 There is also some evidence to suggest male line transmission which would demonstrate true trans-meiotic passage of epigenetic marks.Reference Arpanahi, Brinkworth and Iles118 In line with this, it has been shown that the effects of endocrine disruptors (influencing gonadal development and sex determination when administered early in development), which include an increase in spermatogenic apoptosis and a reduction in sperm motility and number, are mediated by epigenetic processes that persist until at least F4 and are passed via the male line.Reference Anway, Cupp, Uzumcu and Skinner119 The role of non-coding RNAs appears to be central and there is direct experimental evidence of their trans-meiotic transmission.Reference Rassoulzadegan, Grandjean and Gounon120 True transgenerational transmission should be demonstrable by effects induced in F0 persisting to the F3 generation, but such long-term studies are expensive and not frequently performed. It is clear that the part played by epigenetic processes in transgenerational transmission of disease risk requires much more research.

‘Soft’ inheritance can also operate indirectly, via re-creation in each generation of the conditions, which generate certain phenotypic effects in offspring. For instance, small mothers might generate small offspring through reduced uterine size in each generation, and through behaviour such as smoking or food preference which has a familial component.Reference Ibáñez, Potau, Enriquez, Marcos and DeZegher121 The extent to which non-genomic inheritance participates in evolutionary innovation, and the kind of mechanisms that maintain the stability of epigenetic inheritance – leading to genetic assimilation – remain, for the time being, important unresolved issues in evo-devo biology. As they are beyond the scope of this study, the interested reader is referred to other reviews.Reference Jablonka and Raz114, Reference Bossdorf, Richards and Pigliucci122

The global landscape of DOHaD

The demographic pattern of metabolic and cardiovascular disease is rapidly changing: these conditions now affect 1 in 6 adults over the age of 20 years worldwide. Of great concern is the rising risk among young people.Reference O’Flaherty, Ford, Allender, Scarborough and Capewell123 By 2015, an estimated 20 million people a year will die from cardiovascular disease, which accounts for over 40% of all deaths.124 Furthermore, an estimated 300 million people around the world are obese, that is they have a BMI greater than 30 kg/m2, while 155 million school-age children are overweight or obese. Similar trends are being seen in other NCDs, in osteoporosis, atopic diseases, some forms of cancer and cognitive function.

It is of considerable geopolitical importance to note that the epidemic of chronic disease will by 2020 disproportionately occur in countries such as China and India. For both populations, the risk of metabolic and cardiovascular disease occurs at, by Western standards, relatively low waist-hip ratiosReference Whincup, Gilg and Papacosta110, Reference Zhang, Shu and Yang125 and Indians have relative visceral adiposity even at birth.Reference Yajnik, Fall and Coyaji111 We suspect that the high rate of metabolic disease in these two countries has a developmental component, although genetic contributions may also exist. Birth weights are low, mothers are generally of small stature, and the nutritional transition has been rapid. In these populations, we are also seeing the evidence of intergenerational passage of risk.Reference Gluckman, Beedle, Hanson and Yap126 Thus in the first generation mothers are stunted, their offspring are small and at risk of developing obesity through the mismatch pathway. In time, these girls themselves may develop gestational diabetes, switching the pathway in the third generation to a hyperinsulinemic route to obesity.Reference Fall, Stein and Kumaran127 In parts of Asia, the incidence of gestational diabetes is now 10% or greater.Reference Wong and Tan128, Reference Seshiah, Balaji, Balaji, Sanjeevi and Green129 At one time and within one population, four intergenerational cycles may be observed: the cycle of stunted, deprived, disempowered women giving birth to stunted children; then the transition through the mismatch pathway to metabolic disease after a degree of socio-economic development; this is followed by two new emergent cycles of women suffering from gestational diabetes giving birth to children who grow up with a higher risk of diabetes and obese mothers giving birth to children who similarly become obese. With projections for the prevalence of chronic disease in Asia painting a black picture,124 which could have geopolitical ramifications, developmental science is important on a global scale.

This review has not considered many other aspects of the developmental pathways to health and disease; for example, it is clear that a particularly poor start to life is associated with a greater risk of stunting, of cognitive impairment and shorter life. The latter is not limited to increased infant mortality. For example, in The Gambia, the season of birth influences birth weight and longevity, but the differential effect is not manifest until the young adult years.Reference Moore, Cole and Collinson130 The earlier discussion of trade-offs and predictive adaptive responses explains such an observation. It serves to highlight our view that, while the focus of human evo-devo research has been on metabolic disease, as epigenetic tools develop and provide a new approach to epidemiological research, we will find that developmental processes play a much larger part in determining the human condition than is generally accepted.

The implications of this framework

The classification of some diseases as being of developmental origin introduces a new model of disease causation into medicine. In the nineteenth century, modern medicine emerged around the pathological–anatomical model, in which the cause of disease was perceived as a localised lesion. This model fitted well the views of disease derived from bacteriology (and infectious diseases more generally) and genetics. Indeed, the control of infectious diseases and the elucidation of the genetic causes of some diseases have been success stories of modern medicine. Yet this model has not managed to explain the causation of NCD. Fixed genetic variation is now known to account for only a small part of the attributable risk of NCDs such as coronary heart disease, hypertension or type 2 diabetes.Reference Goldstein1, Reference Hirschhorn2 It is now clear that the risk of NCD involves interactions between inheritance, both genomic and otherwise, development and environment.

The concept that perinatal medicine might be the appropriate place to intervene to prevent adult disease inevitably invokes a reaction. When one adds that children do not vote or pay taxes and that the interval between an intervention and any beneficial outcome may take decades, then the political inertia is not surprising. Even the cost-benefit argument for such interventions is not easy to make, because the appropriate economic modelling has not been done. Economic models traditionally discount benefits far into the future and the pressing demands for cutting healthcare expenditure in increasingly ageing populations are hard to counter. But there are signs of change.Reference Gluckman, Hanson and Bateson131 An initial economic model has been publishedReference Alderman and Behrman132 and there is now a major international project addressing this perspective.Reference O’Connor, Morton and Gluckman133

Governments are now beginning to understand the importance of development to human health and patterns of disease. The social inequalities in health commence during development. The recent report of the UK Government Office for Science Foresight GroupReference Butland, Jebb and Kopelman134 concluded that it is important to ‘promote/implement a programme of early interventions at birth or in infancy’ and that ‘intervention in early life generated the highest average impact across all scenarios. It was in these scenarios where it was possible to implement and sustain a life course approach to prevention but also where society was prepared to measure success over longer time frames’. The message is slowly being understood that, for diseases with a developmental origin, the screening and the intervention need to take place during development itself. If not, the intervention may come too late for the affected individuals, and indeed for the next generation. A recent consensus report pointed out that development is a critical context to take into account and that a global standard for development is not realistic, rather each child’s development needs to be assessed within the context of his or her own maternal and population environment: a ‘one size fits all’ programme will not reduce disease risk in many individuals, and may even exacerbate it in others.Reference Gluckman, Hanson and Bateson131

In 2009, the optimal way to promote a healthy life from conception to adulthood in different contexts is still not known. Yet the life course approach is an important and novel concept.Reference Gluckman, Hanson and Bateson131 If epigenetic biomarkers at or soon after birth do prove to be good indicators of the developmental trajectory and of subsequent risk of disease, then we will be able to use them to identify optimal strategies for supporting health before and during pregnancy. This approach will lead to a better identification of vulnerable individuals and groups on one hand, and an improved assessment of information for planning economically modelled interventions. It will also provide the tools and arguments that will show persuasively that the best time in the life course to intervene for long-term advantage is at the very start.

Acknowledgements

Peter D. Gluckman and Tatjana Buklijas are supported by the National Research Centre for Growth and Development. Mark A. Hanson is supported by the British Heart Foundation. We thank Alan Beedle and Felicia Low for editorial assistance and input.

Statement of Interest

None.

References

1.Goldstein, DB. Common genetic variation and human traits. N Engl J Med. 2009; 360, 16961698.CrossRefGoogle ScholarPubMed
2.Hirschhorn, JN. Genome-wide association studies – illuminating biologic pathways. N Engl J Med. 2009; 360, 16991701.CrossRefGoogle ScholarPubMed
3.Chi, KR. Human genetics: hit or miss? Nature. 2009; 461, 712714.CrossRefGoogle ScholarPubMed
4.The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447, 661678.CrossRefGoogle Scholar
5.Maher, B. Personal genomes: the case of the missing heritability. Nature. 2008; 456, 1821.CrossRefGoogle ScholarPubMed
6.Hayden Check, E. Genomics shifts focus to rare diseases. Nature. 2009; 461, 458459.CrossRefGoogle Scholar
7.Allis, CD, Jenuwein, T, Reinberg, D (eds) Epigenetics, 2007. Cold Spring Harbor Laboratory Press: Cold Spring Harbor: NY.Google Scholar
8.Amundsen, R. The Changing Role of the Embryo in Evolutionary Thought: Roots of Evo-Devo, 2005. Cambridge University Press: Cambridge.CrossRefGoogle Scholar
9.Gilbert, SF. Ecological developmental biology: developmental biology meets the real world. Dev Biol. 2001; 233, 112.CrossRefGoogle ScholarPubMed
10.Oyama, S. The Ontogeny of Information: Developmental Systems and Evolution, 1985. Cambridge University Press: Cambridge.Google Scholar
11.Kramer, MS, Joseph, KS. Enigma of fetal/infant-origins hypothesis. Lancet. 1996; 348, 12541255.CrossRefGoogle ScholarPubMed
12.Huxley, R, Neil, A, Collins, R. Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet. 2002; 360, 659665.CrossRefGoogle ScholarPubMed
13.Hopwood, N. Embryology. In The Cambridge History of Science, vol 6: the Modern Biological and Earth Sciences (eds. Bowler PJ, Pickstone JV), 2009; pp. 285315. Cambridge University Press, Cambridge.CrossRefGoogle Scholar
14.Richards, E. A political anatomy of monsters, hopeful and otherwise: teratogeny, transcendentalism, and evolutionary theorizing. Isis. 1994; 85, 377411.Google ScholarPubMed
15.Oppenheimer, JM. Some historical relationships between teratology and experimental embryology. Bull Hist Med. 1968; 42, 145159.Google ScholarPubMed
16.Gliboff, S. “Protoplasm…is soft wax in our hands”: Paul Kammerer and the art of biological transformation. Endeavour. 2005; 29, 162167.CrossRefGoogle ScholarPubMed
17.Vargas, AO. Did Paul Kammerer discover epigenetic inheritance? a modern look at the controversial midwife toad experiments. J Exp Zool (Mol Dev Evo). 2009; 312B, 667678.CrossRefGoogle Scholar
18.Roll-Hansen, N. The Lysenko Effect: The Politics of Science, 2005. Humanity Books: Amherst, NJ.Google Scholar
19.Kermack, W, McKendrick, A, McKinlay, P. Death rates in Great Britain and Sweden: some general regularities and their significance. Lancet. 1934; 223, 698703.CrossRefGoogle Scholar
20.Dörner, G. Die mögliche Bedeutung der prä- und/oder perinatalen Ernährung für die Pathogenese der Obesitas. Acta Biol Med Ger. 1973; 30, 1922.Google Scholar
21.Dörner, G, Götz, F. Hyperglikämie und Übergewicht in neonatal insulinbehandelten erwachsenen Rättenmänchen. Acta Biol Med Ger. 1972; 29, 467470.Google Scholar
22.Dörner, G, Haller, K, Leonhardt, M. Zur möglichen Bedeutung der prä- und/oder früh postnatalen Ernährung für die Pathogenese der Arterioskleroze. Acta Biol Med Ger. 1973; 31, 3135.Google Scholar
23.Dörner, G, Mohnike, A. Zur möglichen Bedeutung der prä- und/oder frühpostnatalen Ernährung für die Pathogenese der Diabetes Mellitus. Acta Biol Med Ger. 1973; 31, 710.Google ScholarPubMed
24.Dörner, G, Rodekamp, E, Plagemann, A. Maternal deprivation and overnutrition in early postnatal life and their primary prevention: historical reminiscence of an “ecological” experiment in Germany. Hum ontogenet. 2008; 2, 5159.CrossRefGoogle Scholar
25.Lucas, A. Programming by early nutrition in man. (discussion 50-55) Ciba Found Symp. 1991; 156, 3850.Google ScholarPubMed
26.Dörner, G. Günter Dörner, endocrinologist. Hum Ontogenet. 2008; 2, 59.CrossRefGoogle Scholar
27.Freinkel, N. Banting lecture 1980. Of pregnancy and progeny. Diabetes. 1980; 29, 10231035.CrossRefGoogle ScholarPubMed
28.De Prins, FA, Van Assche, FA. Intrauterine growth retardation and development of endocrine pancreas in the experimental rat. Biologia Neonatorum. 1982; 41, 1621.Google Scholar
29.Aerts, L, Van Assche, FA. Is gestational diabetes an acquired condition? J Dev Physiol. 1979; 1, 219225.Google ScholarPubMed
30.Forsdahl, A. Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease? Br J Prevent Soc Med. 1977; 31, 9195.Google ScholarPubMed
31.Wadsworth, ME, Cripps, HA, Midwinter, RE, Colley, JR. Blood pressure in a national birth cohort at the age of 36 related to social and familial factors, smoking, and body mass. Br Med J (Clin Res Ed). 1985; 291, 15341538.Google Scholar
32.Notkola, V, Punsar, S, Karvonen, MJ, Haapakoski, J. Socio-economic conditions in childhood and mortality and morbidity caused by coronary heart disease in adulthood in rural Finland. Soc Sci Med. 1985; 21, 517523.CrossRefGoogle ScholarPubMed
33.Barker, DJ, Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986; 1, 10771081.CrossRefGoogle ScholarPubMed
34.Gennser, G, Rymark, P, Isberg, PE. Low birth weight and risk of high blood pressure in adulthood. Br Med J (Clin Res Ed). 1988; 296, 14981500.CrossRefGoogle ScholarPubMed
35.Pettitt, DJ, Aleck, KA, Baird, HR, Carraher, MJ, Bennett, PH, Knowler, WC. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes. 1988; 37, 622628.CrossRefGoogle ScholarPubMed
36.Godfrey, K. The ‘developmental origins’ hypothesis: epidemiology. In Developmental Origins of Health and Disease (eds. Gluckman PD, Hanson MA), 2006; pp. 632. Cambridge University Press, Cambridge.CrossRefGoogle Scholar
37.Cooper, C, Walker-Bone, K, Arden, N, Dennison, E. Novel insights into the pathogenesis of osteoporosis: the role of intrauterine programming. Rheumatology. 2000; 39, 13121315.CrossRefGoogle ScholarPubMed
38.Gale, CR, Martyn, CN. Birth weight and later risk of depression in a national birth cohort. Br J Psychiatry. 2004; 184, 2833.CrossRefGoogle Scholar
39.Wahlbeck, K, Forsen, T, Osmond, C, Barker, DJP, Eriksson, JG. Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood. Arch Gen Psych. 2001; 58, 4852.CrossRefGoogle ScholarPubMed
40.Barker, DJ, Godfrey, KM, Fall, C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. Br Med J. 1991; 303, 671675.CrossRefGoogle ScholarPubMed
41.Ahlgren, M, Melbye, M, Wohlfahrt, J, Sorensen, TIA. Growth patterns and the risk of breast cancer in women. New Engl J Med. 2004; 351, 16191626.CrossRefGoogle ScholarPubMed
42.Jefferis, BJMH, Power, C, Hertzman, C. Birth weight, childhood socioeconomic environment, and cognitive development in the 1958 British birth cohort study. Br Med J. 2002; 325, 305311.CrossRefGoogle ScholarPubMed
43.Harding, JE. The nutritional basis of the fetal origins of adult disease. Int J Epidemiol. 2001; 30, 1523.Google Scholar
44.McMullen, S, Mostyn, A. Animal models for the study of the developmental origins of health and disease. Proc Nutr Soc. 2009; 68, 306320.Google Scholar
45.Mayr, E. Cause and effect in biology. Science. 1961; 134, 15011506.Google Scholar
46.Cohen, MN, Armelagos, GJ (eds) Paleopathology at the Origins of Agriculture. Academic Press: Orlando, 1984.Google Scholar
47.Neel, JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962; 14, 353362.Google ScholarPubMed
48.Kuzawa, CW, Gluckman, PD, Hanson, MA, Fantuzzi, G, Mazzone, T. Developmental perspectives on the origin of obesity. In Adipose Tissue and Adipokines in Health and Disease (eds. Fantuzzi G, Mazzone T), 2007; pp. 207219. Humana Press: Totowa, NJ.Google Scholar
49.Hales, CN, Barker, DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992; 35, 595601.CrossRefGoogle ScholarPubMed
50.Denver, R, Mirhadi, N, Phillips, M. Adaptive plasticity in amphibian metamorphosis: response of Scaphiopus hammondii tadpoles to habitat desiccation. Ecology. 1998; 79, 18591872.Google Scholar
51.Reusens, B, Remacle, C. Programming of impaired insulin secretion versus sensitivity: cause or effect?. In Early Nutrition Programming and Health Outcomes in Later Life: Obesity and Beyond (eds. Koletzko B, Decsi T, Molnar D, de La Hunty A), 2009; pp. 125131. Springer, Netherlands, Dordrecht.Google Scholar
52.Dawes, GS, Borruto, F, Zacutti, A (eds) Fetal Autonomy and Adaptation, 1990. Wiley: Chichester.Google Scholar
53.Bateson, P. Fetal experience and good adult design. Int J Epidemiol. 2001; 30, 928934.Google Scholar
54.Gluckman, PD, Hanson, MA. Living with the past: evolution, development, and patterns of disease. Science. 2004; 305, 17331736.CrossRefGoogle ScholarPubMed
55.Bateson, P, Barker, D, Clutton-Brock, T, et al. Developmental plasticity and human health. Nature. 2004; 430, 419421.CrossRefGoogle ScholarPubMed
56.Gluckman, PD, Hanson, MA, Spencer, HG, Bateson, P. Environmental influences during development and their later consequences for health and disease: implications for the interpretation of empirical studies. Proc Royal Soc Lond B. 2005; 272, 671677.Google ScholarPubMed
57.Gluckman, PD, Hanson, MA, Spencer, HG. Predictive adaptive responses and human evolution. Trends Ecol Evol. 2005; 20, 527533.CrossRefGoogle ScholarPubMed
58.Gluckman, PD, Hanson, MA, Beedle, AS. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol. 2007; 19, 119.CrossRefGoogle ScholarPubMed
59.Applebaum, SW, Heifetz, Y. Density-dependent physiological phase in insects. Annu Rev Entomol. 1999; 44, 317341.CrossRefGoogle ScholarPubMed
60.Desai, M, Gayle, D, Babu, J, Ross, MG. Programmed obesity in intrauterine growth restricted newborns: modulation by newborn nutrition. Am J Physiol. 2005; 288, R91R96.Google Scholar
61.Sloboda, DM, Howie, GJ, Vickers, MH. Early-onset puberty in offspring after maternal undernutrition is exaggerated by a post-weaning high fat diet: sex specific evidence of nutritional mismatch. Early Hum Dev. 2007; 83(Suppl 1), S65S66.CrossRefGoogle Scholar
62.Mitchell, A, Romano, GH, Groisman, B, et al. Adaptive prediction of environmental changes by microorganisms. Nature. 2009; 460, 220224.CrossRefGoogle ScholarPubMed
63.Jablonka, E, Oborny, B, Molnar, I, et al. The adaptive advantage of phenotypic memory in changing environments. Philos Trans R Soc Lond B Biol Sci. 1995; 350, 133141.Google ScholarPubMed
64.Moran, NA. The evolutionary maintenance of alternative phenotypes. Am Nat. 1992; 139, 971989.CrossRefGoogle Scholar
65.Gluckman, PD, Hanson, MA. The Fetal Matrix: Evolution, Development, and Disease, 2005. Cambridge University Press: Cambridge.Google Scholar
66.Kuzawa, CW. Fetal origins of developmental plasticity: are fetal cues reliable predictors of future nutritional environments? Am J Hum Biol. 2005; 17, 521.Google Scholar
67.Bloomfield, FH, Oliver, MH, Hawkins, P, et al. A periconceptional nutritional origin for non-infectious preterm birth. Science. 2003; 300, 606.CrossRefGoogle Scholar
68.Ronnenberg, AG, Wang, X, Xing, H, et al. Low preconception body mass index is associated with birth outcome in a prospective cohort of Chinese women. J Nutr. 2003; 133, 34493455.Google Scholar
69.Boyne, MS, Thame, M, Bennett, FI, et al. The relationship among circulating insulin-like growth factor (IGF-1), IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. J Clin Endocrinol Metab. 2003; 88, 16871691.CrossRefGoogle ScholarPubMed
70.Wells, JCK. The thrifty phenotype as an adaptive maternal effect. Biol Rev Camb Philos Soc. 2007; 82, 143172.CrossRefGoogle ScholarPubMed
71.Smith, CA. Effects of maternal undernutrition upon the newborn infant in Holland (1944–45). J Pediatr. 1947; 30, 229243.CrossRefGoogle Scholar
72.Painter, RC, Roseboom, TJ, Bleker, OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol. 2005; 20, 345352.Google Scholar
73.MacLaughlin, SM, Walker, SK, Roberts, CT, Kleemann, DO, McMillen, IC. Periconceptional nutrition and the relationship between maternal body weight changes in the periconceptional period and feto-placental growth in the sheep. J Physiol. 2005; 565, 111124.CrossRefGoogle ScholarPubMed
74.Sloboda, DM, Hart, R, Doherty, DA, Pennell, CE, Hickey, M. Age at menarche: influences of prenatal and postnatal growth. J Clin Endocrinol Metab. 2007; 92, 4650.Google Scholar
75.Gale, CR, Jiang, B, Robinson, SM, et al. Maternal diet during pregnancy and carotid intima-media thickness in children. Arterioscler Thromb Vasc Biol. 2006; 26, 18771882.Google Scholar
76.Gluckman, PD, Hanson, MA. Mismatch: Why our World no Longer fits our Bodies, 2006. Oxford University Press: Oxford.Google Scholar
77.Gluckman, PD, Hanson, MA. Maternal constraint of fetal growth and its consequences. Semin Fetal Neonatal Med. 2004; 9, 419425.Google Scholar
78.Sultan, SE, Spencer, HG. Metapopulation structure favors plasticity over local adaptation. Am Nat. 2002; 160, 271283.CrossRefGoogle ScholarPubMed
79.Cordain, L, Eaton, SB, Sebastian, A, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005; 81, 341354.Google Scholar
80.Norman, JF, LeVeen, RF. Maternal atherogenic diet in swine is protective against early atherosclerosis development in offspring consuming an atherogeneic diet post-natally. Atherosclerosis. 2001; 157, 4147.Google Scholar
81.Forsen, T, Eriksson, J, Tuomilehto, J, et al. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med. 2000; 133, 176182.Google Scholar
82.Gluckman, PD, Hanson, MA, Beedle, AS, Raubenheimer, D. Fetal and neonatal pathways to obesity. Front Horm Res. 2008; 36, 6172.CrossRefGoogle ScholarPubMed
83.Pettitt, DJ, Lawrence, JM, Beyer, J, et al. Association between maternal diabetes in utero and age at offspring’s diagnosis of type 2 diabetes. Diabetes Care. 2008; 31, 21262130.CrossRefGoogle ScholarPubMed
84.McCurdy, CE, Bishop, JM, Williams, SM, et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest. 2009; 119, 323335.Google ScholarPubMed
85.Stettler, N, Tershakovec, AM, Zemel, BS, et al. Early risk factors for increased adiposity: a cohort study of African American subjects followed from birth to young adulthood. Am J Clin Nutr. 2000; 72, 378383.Google Scholar
86.Lawlor, DA, Timpson, NJ, Harbord, RM, et al. Exploring the developmental overnutrition hypothesis using parental-offspring associations and FTO as an instrumental variable. PLoS Med. 2008; 5, 04840493.Google Scholar
87.Sloboda, DM, Howie, GJ, Pleasants, A, Gluckman, PD, Vickers, MH. Pre- and postnatal nutritional histories influence reproductive maturation and ovarian function in the rat. PLoS One. 2009; 4, 18.Google Scholar
88.Hanson, M, Fall, C, Robinson, S, Baird, J. Early Life Nutrition and Lifelong Health, 2009. British Medical Association: London.Google Scholar
89.Meaney, MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci. 2001; 24, 11611192.CrossRefGoogle Scholar
90.Ross, MG, Desai, M, Guerra, C, Wang, S. Prenatal programming of hypernatremia and hypertension in neonatal lambs. Am J Physiol. 2005; 288, R25R33.Google Scholar
91.Diamond, J. Pearl Harbor and the Emperor’s physiologists. Nat Hist. 1991, 27.Google ScholarPubMed
92.Gluckman, PD, Hanson, MA, Cooper, C, Thornburg, KL. Effect of in utero and early-life conditions on adult health and disease. New Engl J Med. 2008; 359, 6173.CrossRefGoogle ScholarPubMed
93.Bertram, C, Trowern, AR, Copin, N, Jackson, AA, Whorwood, CB. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology. 2001; 142, 28412853.Google Scholar
94.Reik, W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007; 447, 425432.CrossRefGoogle ScholarPubMed
95.Lillycrop, KA, Phillips, ES, Jackson, AA, Hanson, MA, Burdge, GC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr. 2005; 135, 13821386.Google Scholar
96.Lillycrop, KA, Slater-Jefferies, JL, Hanson, MA, et al. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr. 2007; 97, 10641073.CrossRefGoogle ScholarPubMed
97.Park, JH, Stoffers, DA, Nicholls, RD, Simmons, RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008; 118, 23162324.Google Scholar
98.Aagaard-Tillery, KM, Grove, K, Bishop, J, et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol. 2008; 41, 91102.CrossRefGoogle ScholarPubMed
99.Sinclair, KD, Allegrucci, C, Singh, R, et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci USA. 2007; 104, 1935119356.CrossRefGoogle ScholarPubMed
100.Tobi, EW, Lumey, LH, Talens, RP, et al. DNA Methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009; 18, 40464053.Google Scholar
101.Amaral, PP, Dinger, ME, Mercer, TR, Mattick, JS. The eukaryotic genome as an RNA machine. Science. 2008; 319, 17871789.CrossRefGoogle ScholarPubMed
102.Vickers, MH, Gluckman, PD, Coveny, AH, et al. Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005; 146, 42114216.CrossRefGoogle ScholarPubMed
103.Gluckman, PD, Lillycrop, KA, Vickers, MH, et al. Metabolic plasticity during mammalian development is directionally dependent on early nutritional status. Proc Natl Acad Sci USA. 2007; 104, 1279612800.Google Scholar
104.Bouret, SG, Simerly, RB. Leptin and development of hypothalamic feeding circuits. Endocrinology. 2004; 145, 26212626.CrossRefGoogle ScholarPubMed
105.Delahaye, F, Breton, C, Risold, PY, et al. Maternal perinatal undernutrition drastically reduces postnatal leptin surge and affects the development of arcuate nucleus proopiomelanocortin neurons in neonatal male rat pups. Endocrinology. 2008; 149, 470475.Google Scholar
106.Morioka, T, Asilmaz, E, Hu, J, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest. 2007; 117, 28602868.Google Scholar
107.Elinav, E, Niv-Spector, L, Price, TO, et al. Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology. 2009; 150, 30833091.CrossRefGoogle ScholarPubMed
108.Stoffers, DA, Desai, BM, DeLeon, DD, Simmons, RA. Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes. 2003; 52, 734740.CrossRefGoogle ScholarPubMed
109.Wyrwoll, CS, Mark, PJ, Mori, TA, Puddey, IB, Waddell, BJ. Prevention of programmed hyperleptinemia and hypertension by postnatal dietary omega-3 fatty acids. Endocrinology. 2006; 147, 599606.Google Scholar
110.Whincup, PH, Gilg, JA, Papacosta, O, et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. Br Med J. 2002; 324, 16.CrossRefGoogle ScholarPubMed
111.Yajnik, CS, Fall, CHD, Coyaji, KJ, et al. Neonatal anthropometry: the thin-fat Indian baby. The Pune maternal nutrition study. Int J Obes. 2003; 27, 173180.Google Scholar
112.Jahoor, F, Badaloo, A, Reid, M, et al. Unique metabolic characteristics of the major syndromes of severe childhood malnutrition. In The Tropical Metabolism Research Unit, The University of the West Indies, Jamaica 1956–2006: The House that John Built (eds. Forrester T, Picou D, Walker S), 2007; pp. 2360. Ian Randle Publishers, Kingston.Google Scholar
113.Godfrey, KM, Gluckman, PD, Lillycrop, KA, et al. Epigenetic marks at birth predict childhood body composition at age 9 years. Abstract O-8A-72 presented at the 6th World Congress of Developmental Origins of Health and Disease, Santiago de Chile, November 2009. J DOHaD. 2009; 1(Suppl. 1), S44.Google Scholar
114.Jablonka, E, Raz, G. Transgenerational epigenetic inheritance: prevalence, mechanisms, and implications for the study of heredity and evolution. Q Rev Biol. 2009; 84, 131176.Google Scholar
115.Burdge, GC, Hanson, MA, Slater-Jeffries, JL, Lillycrop, KA. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? Br J Nutr. 2007; 97, 10361046.Google Scholar
116.Gluckman, PD, Hanson, MA, Beedle, AS. Non-genomic transgenerational inheritance of disease risk. Bioessays. 2007; 29, 149154.Google Scholar
117.Waterland, RA, Travisano, M, Tahiliani, KG, Rached, MT, Mirza, S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int J Obes. 2008; 32, 13731379.Google Scholar
118.Arpanahi, A, Brinkworth, M, Iles, D, et al. Endonuclease-sensitive regions of human spermatozoal chromatin are highly enriched in promoter and CTCF binding sequences. Gen Res. 2009; 19, 13381349.Google Scholar
119.Anway, MD, Cupp, AS, Uzumcu, M, Skinner, MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005; 308, 14661469.CrossRefGoogle ScholarPubMed
120.Rassoulzadegan, M, Grandjean, V, Gounon, P, et al. RNA-mediated non-Mendelian inheritance of an epigenetic change in the mouse. Nature. 2006; 441, 469474.Google Scholar
121.Ibáñez, L, Potau, N, Enriquez, G, Marcos, MV, DeZegher, F. Hypergonadotrophinaemia with reduced uterine and ovarian size in women born small-for-gestational-age. Hum Reprod. 2003; 18, 15651569.Google Scholar
122.Bossdorf, O, Richards, CL, Pigliucci, M. Epigenetics for ecologists. Ecol Lett. 2008; 11, 106115.CrossRefGoogle ScholarPubMed
123.O’Flaherty, M, Ford, E, Allender, S, Scarborough, P, Capewell, S. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart. 2008; 94, 178181.Google Scholar
124.WHO. Preventing Chronic Diseases: a Vital Investment. 2005. World Health Organization: Geneva.Google Scholar
125.Zhang, XL, Shu, XO, Yang, G, et al. Abdominal adiposity and mortality in Chinese women. Arch Int Med. 2007; 167, 886892.Google Scholar
126.Gluckman, PD, Beedle, AS, Hanson, MA, Yap, EP. Developmental perspectives on individual variation: implications for understanding nutritional needs. In Personalized Nutrition for the Diverse Needs of Infants and Children (eds. Bier DM, German JB, Lonnerdal B), 2008; pp. 112. Karger, Basel.Google Scholar
127.Fall, CH, Stein, CE, Kumaran, K, et al. Size at birth, maternal weight, and type 2 diabetes in South India. Diabet Med. 1998; 15, 220227.Google Scholar
128.Wong, L, Tan, ASA. The glucose challenge test for screening gestational diabetes in pregnant women with no risk factors. Singapore Med J. 2001; 42, 517521.Google Scholar
129.Seshiah, V, Balaji, V, Balaji, MS, Sanjeevi, CB, Green, A. Gestational diabetes mellitus in India. J Assoc Physicians India. 2004; 52, 707711.Google Scholar
130.Moore, SE, Cole, TJ, Collinson, AC, et al. Prenatal or early postnatal events predict infectious deaths in young adulthood in rural Africa. Int J Epidemiol. 1999; 28, 10881095.Google Scholar
131.Gluckman, PD, Hanson, MA, Bateson, P, et al. Towards a new developmental synthesis: adaptive developmental plasticity and human disease. Lancet. 2009; 373, 16541657.Google Scholar
132.Alderman, H, Behrman, JR. Estimated Economic Benefits of Reducing low Birth Weight in low-income Countries. Health, Nutrition and Population (HNP) Discussion Paper of the World Bank’s Human Development Network. 2004. World Bank: Washington, DC.Google Scholar
133.O’Connor, KC, Morton, SMB, Gluckman, PD. Modelling the economic antecedents and costs of low birth weight: multidimensional challenges in the international poor start to life project. Early Hum Dev. 2007; 83(Suppl 1), S39.Google Scholar
134.Butland, B, Jebb, S, Kopelman, P, et al. Tackling Obesities: Future Choices (Foresight Project Report), 2008. Government Office for Science: London.Google Scholar